In thrombosed native AVFs, pharmacomechanical thrombectomy and thrombolysis with balloon maceration provide similar safety profiles and long-term patency outcomes. Patency and reintervention are primarily influenced by thrombus load, access anatomy, and patient-related factors rather than device selection, supporting a lesion-oriented and individualized endovascular treatment strategy.
Dilek et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: